Form 8-K

8-K — CTS CORP

Accession: 0001193125-26-318911

Filed: 2026-07-28

Period: 2026-07-28

CIK: 0000026058

SIC: 3672 (PRINTED CIRCUIT BOARDS)

Item: Results of Operations and Financial Condition

Item: Regulation FD Disclosure

Item: Financial Statements and Exhibits

Documents

8-K — cts-20260728.htm (Primary)

EX-99.1 (cts-ex99_1.htm)

EX-99.2 (cts-ex99_2.htm)

GRAPHIC (img192797187_0.jpg)

GRAPHIC (cts-ex99_2s1.jpg)

GRAPHIC (cts-ex99_2s2.jpg)

GRAPHIC (cts-ex99_2s3.jpg)

GRAPHIC (cts-ex99_2s4.jpg)

GRAPHIC (cts-ex99_2s5.jpg)

GRAPHIC (cts-ex99_2s6.jpg)

GRAPHIC (cts-ex99_2s7.jpg)

GRAPHIC (cts-ex99_2s8.jpg)

GRAPHIC (cts-ex99_2s9.jpg)

GRAPHIC (cts-ex99_2s10.jpg)

GRAPHIC (cts-ex99_2s11.jpg)

GRAPHIC (cts-ex99_2s12.jpg)

GRAPHIC (cts-ex99_2s13.jpg)

GRAPHIC (cts-ex99_2s14.jpg)

GRAPHIC (cts-ex99_2s15.jpg)

GRAPHIC (cts-ex99_2s16.jpg)

GRAPHIC (cts-ex99_2s17.jpg)

GRAPHIC (cts-ex99_2s18.jpg)

GRAPHIC (cts-ex99_2s19.jpg)

XML — IDEA: XBRL DOCUMENT (R1.htm)

8-K

8-K (Primary)

Filename: cts-20260728.htm · Sequence: 1

8-K

false000002605800000260582026-07-282026-07-28

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): July 28, 2026

CTS CORPORATION

(Exact name of Registrant as Specified in Its Charter)

Indiana

1-4639

35-0225010

(State or Other Jurisdiction

of Incorporation)

(Commission File Number)

(I.R.S. Employer

Identification No.)

4925 Indiana Avenue

Lisle, Illinois

60532

(Address of Principal Executive Offices)

(Zip Code)

Registrant’s Telephone Number, Including Area Code: (630) 577-8800

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading

Symbol(s)

Name of each exchange on which registered

Common Stock, no par value

CTS

The New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02 Results of Operations and Financial Condition.

On July 28, 2026, CTS Corporation (the "Company") issued a press release providing certain results for the second quarter ended June 30, 2026, as more fully described in the press release. A copy of the press release is attached hereto as Exhibit 99.l and is incorporated by reference herein.

The information contained in Item 2.02 of this Current Report on Form 8-K, including Exhibit 99.l hereto, is being "furnished" to the Securities and Exchange Commission and shall not be deemed to be "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section. Furthermore, such information shall not be deemed to be incorporated by reference into any filing made by the Company under the Securities Act of 1933 (the “Securities Act”) or the Exchange Act, except as set forth by specific reference in such filing.

Item 7.01 Regulation FD Disclosure.

As disclosed in the press release furnished as Exhibit 99.1, the Company will hold a live web cast on July 28, 2026, relating to the Company's financial results for the second quarter ended June 30, 2026. A copy of the slides to be presented during the Company's web cast and discussed in the conference call relating to such financial results is being furnished as Exhibit 99.2 to this Current Report on Form 8-K.

By filing this Current Report on Form 8-K and furnishing the information contained herein, the Company makes no admission as to the materiality of any information in this report that is required to be disclosed solely by reason of Regulation FD.

The information contained in Item 7.01 of this Current Report on Form 8-K and Exhibit 99.2 shall not be deemed to be “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section. Furthermore, such information shall not be deemed to be incorporated by reference into any filing made by the Company under the Securities Act or the Exchange Act, except as set forth by specific reference in such filing.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

Exhibit

Description

99.1

Earnings Release dated July 28, 2026

99.2

Slides of CTS Corporation, 2nd Quarter 2026, dated July 28, 2026

104

Cover Page Interactive Data File (embedded within the Inline XBRL Document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: July 28, 2026

CTS CORPORATION

By:

/s/ Ashish Agrawal

Ashish Agrawal

Vice President and Chief Financial Officer

EX-99.1

Filename: cts-ex99_1.htm · Sequence: 2

EX-99.1

Exhibit 99.1

July 28, 2026

FOR IMMEDIATE RELEASE

CTS Announces Second Quarter 2026 Results

Strong diversification momentum drives record margins and profitability; 2026 outlook raised

Lisle, Ill. - CTS Corporation (NYSE: CTS), a leading global designer and manufacturer of highly engineered solutions that “Sense, Connect and Move,” today announced results for the second quarter of 2026.

“CTS’s diversification strategy is translating into stronger, more resilient performance with those end market sales up 15% year over year and now represent 59% of total revenue. Transportation sales modestly declined with strong growth in new wins,” said Pratik Trivedi, CEO of CTS Corporation. “We delivered another quarter of outstanding execution, driving profitable growth, record margins, and strong cash generation. Our focus remains on the transformation of our portfolio through continued growth in our diversified end markets to accelerate long term value creation.”

Second Quarter 2026 Results

•

Sales were $144.8 million in the second quarter of 2026, up 7% year-over-year. Sales to diversified end-markets increased 15%. Sales to the transportation market decreased 2%.

•

Net income was $19.2 million, or 13.2% of sales, compared to $18.5 million, or 13.7% of sales in the second quarter of 2025.

•

Diluted EPS was $0.66, up 4 cents from $0.62 in the second quarter of 2025.

•

Adjusted Gross margin was 41.5%, up 270 bps from 38.7% in the second quarter of 2025.

•

Adjusted EBITDA margin was 25.4%, up 240 bps from 23.0% in the second quarter of 2025.

•

Adjusted diluted EPS was $0.74, up 17 cents from $0.57 in the second quarter of 2025.

•

Operating cash flow was $33.4 million, up $5.0 million from $28.4 million in the second quarter of 2025.

2026 Guidance

Assuming the continuation of current market conditions, CTS is increasing its previous guidance of 2026 sales from a range of $560-$580 million to $565-$585 million and adjusted diluted EPS from a range of $2.35-$2.45 to $2.55-$2.70.

CTS does not provide reconciliations of forward-looking non-GAAP financial measures, such as estimated adjusted diluted earnings per share, to the most comparable GAAP financial measures on a forward-looking basis because CTS is unable to provide a meaningful or accurate calculation or estimation of reconciling items and the information is not available without unreasonable effort. This is due to the inherent difficulty of forecasting the timing and amount of certain items, such as, but not limited to, restructuring costs, environmental remediation costs, acquisition-related costs, foreign exchange rates and other non-routine costs. Each of such adjustments has not yet occurred, are out of CTS' control and/or cannot be reasonably predicted. For the same reasons, CTS is unable to address the probable significance of the unavailable information.

www.ctscorp.com

Conference Call and Supplemental Materials

As previously announced, CTS has scheduled a conference call for 10:00 a.m. (ET) today.The conference call can be accessed by registering online at CTS Corporation Q2 2026 Earnings Call, at which time registrants will receive dial-in information as well as a conference ID. In addition, CTS will be using a supplemental slide presentation that will be referred to during the call. The presentation and a live audio webcast of the conference call will be available and can be accessed directly from CTS’ website at https://investors.ctscorp.com/news-events/events-and-presentations/.

Any replay, rebroadcast, transcript or other reproduction or transmission of this conference call, other than the replay accessible through the website noted above, has not been authorized by CTS and is strictly prohibited. Investors should be aware that any unauthorized reproduction of this conference call may not be an accurate reflection of its contents.

About CTS

CTS Corporation (NYSE: CTS) is a leading designer and manufacturer of products that Sense, Connect and Move. CTS manufactures sensors, actuators and electronic components in North America, Europe and Asia, and provides engineered products to customers in the aerospace & defense, industrial, medical and transportation markets. For more information, visit www.ctscorp.com/.

Diversified end markets, previously referred as the “non-transportation” market, includes the industrial, aerospace & defense, and medical end markets.

www.ctscorp.com

Cautionary Statement Regarding Forward-Looking Statements

Readers are cautioned that the statements contained in this document regarding expectations of our performance or other matters that may affect our business, results of operations, or financial condition are, or may be deemed to be, “forward-looking statements” as defined by the “safe harbor” provisions in the Private Securities Litigation Reform Act of 1995. Such statements are made in reliance on the safe harbor provisions of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All statements, other than statements of historical fact, included or incorporated in this document, including statements regarding our strategy, financial position, guidance, funding for continued operations, cash reserves, liquidity, projected costs, plans, projects, awards and contracts, and objectives of management, among others, are forward-looking statements. Words such as “expect,” “anticipate,” “should,” “believe,” “hope,” “target,” “continued,” “project,” “plan,” “goals,” “opportunity,” “appeal,” “estimate,” “potential,” “predict,” “demonstrates,” “may,” “will,” “might,” “could,” “intend,” “shall,” “possible,” “would,” “approximately,” “likely,” “outlook,” “schedule,” “on track,” “poised,” “pipeline,” and variations of these terms or the negative of these terms and similar expressions are intended to identify these forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. These forward-looking statements are not guarantees of future performance, conditions or results. Forward-looking statements are based on management’s expectations, certain assumptions, and currently available information. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof and are based on various assumptions as to future events, the occurrence of which necessarily are subject to uncertainties. These forward-looking statements are made subject to certain risks, uncertainties, and other factors, which could cause CTS’ actual results, performance, or achievements to differ materially from those presented in the forward-looking statements. Examples of factors that may affect future operating results and financial condition include, but are not limited to: supply chain disruptions (including, but not limited to, the availability and cost of rare earth elements, minerals and metals); changes in the economy generally, including inflationary and/or recessionary conditions and increased tariffs, and in respect to the businesses in which CTS operates; unanticipated issues in integrating acquisitions; the funding of contracts by the U.S. Government; the results of actions to reposition CTS’ business; rapid technological change; general market conditions in the transportation, as well as conditions in the industrial, aerospace and defense, and medical markets; reliance on key customers; unanticipated public health crises, natural disasters or other events; environmental compliance and remediation expenses; the ability to protect CTS’ intellectual property; pricing pressures and demand for CTS’ products; risks associated with CTS’ international operations, including trade and tariff barriers, trade pacts, including the future of the USMCA, exchange rates and political and geopolitical risks (including, without limitation, the impact of tariffs on China, Canada and Mexico, and other nations, the potential impact of U.S./China relations and the impact of geopolitical conflicts may have on our business, results of operations and financial condition; write offs of goodwill on our balance sheet; the amount and timing of any share repurchases; and the effect of any cybersecurity incidents on our business. Many of these, and other risks and uncertainties, are discussed in further detail in Item 1A. of CTS's most recent Annual Report on Form 10-K and other filings made with the SEC. CTS undertakes no obligation to publicly update CTS’ forward-looking statements to reflect new information or events or circumstances that arise after the date hereof, including market or industry changes.

Contact

Ashish Agrawal

Vice President and Chief Financial Officer

CTS Corporation

4925 Indiana Avenue

Lisle, IL 60532 USA

+1 (630) 577-8800

ashish.agrawal@ctscorp.com

www.ctscorp.com

CTS CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF EARNINGS - UNAUDITED

(In thousands, except per share amounts)

Three Months Ended

Six Months Ended

June 30,

2026

June 30,

2025

June 30,

2026

June 30,

2025

Net sales

144,780

135,309

284,010

261,078

Cost of goods sold

84,732

82,878

168,976

162,099

Gross margin

60,048

52,431

115,034

98,979

Selling, general and administrative expenses

28,390

23,077

54,373

46,700

Research and development expenses

4,763

6,326

11,398

12,515

Restructuring charges

297

480

749

Operating earnings

26,801

22,731

48,783

39,015

Other (expense) income:

Interest expense

(704

)

(1,121

)

(1,412

)

(2,289

)

Interest income

571

622

1,051

1,068

Other (expense) income, net

(430

)

750

(511

)

1,307

Total other (expense) income, net

(563

)

251

(872

)

Earnings before income taxes

26,238

22,982

47,911

39,101

Income tax expense

7,074

4,455

11,550

7,210

Net earnings

19,164

18,527

36,361

31,891

Earnings per share:

Basic

0.67

0.62

1.27

1.07

Diluted

0.66

0.62

1.26

1.06

Basic weighted – average common shares outstanding:

28,580

29,739

28,634

29,875

Effect of dilutive securities

329

251

317

285

Diluted weighted – average common shares outstanding:

28,909

29,990

28,951

30,160

Cash dividends declared per share

0.04

0.08

www.ctscorp.com

CTS CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands of dollars)

(Unaudited)

June 30,

2026

December 31, 2025

ASSETS

Current Assets

Cash and cash equivalents

107,536

82,295

Accounts receivable, net of allowances of $673 and $910, respectively

92,157

88,096

Inventories, net

59,588

52,854

Other current assets

27,099

29,461

Total current assets

286,380

252,706

Property, plant and equipment, net

89,113

89,741

Operating lease assets, net

32,142

22,542

Other Assets

Goodwill

208,064

209,611

Other intangible assets, net

144,069

153,562

Deferred income taxes

21,566

25,110

Other assets

10,196

11,039

Total other assets

383,895

399,322

Total Assets

791,530

764,311

LIABILITIES AND SHAREHOLDERS’ EQUITY

Current Liabilities

Accounts payable

49,955

48,220

Operating lease obligations

4,377

3,453

Accrued payroll and benefits

19,279

20,732

Accrued expenses and other liabilities

36,174

37,283

Total current liabilities

109,785

109,688

Long-term debt

55,000

57,500

Long-term operating lease obligations

30,511

21,841

Long-term pension obligations

3,671

3,698

Deferred income taxes

12,531

12,800

Other long-term obligations

7,217

6,998

Total Liabilities

218,715

212,525

Commitments and Contingencies

Shareholders’ Equity

Common stock

326,815

324,982

Additional contributed capital

43,208

43,303

Retained earnings

747,540

713,467

Accumulated other comprehensive income

11,019

13,748

Total shareholders’ equity before treasury stock

1,128,582

1,095,500

Treasury stock

(555,767

)

(543,714

)

Total shareholders’ equity

572,815

551,786

Total Liabilities and Shareholders’ Equity

791,530

764,311

www.ctscorp.com

CTS CORPORATION AND SUBSIDIARIES

OTHER SUPPLEMENTAL INFORMATION - UNAUDITED

(In millions of dollars, except percentages and per share amounts)

Non-GAAP Financial Measures

From time to time, CTS may use non-GAAP financial measures in discussing CTS’ business. These measures are intended to supplement, not replace, CTS’ presentation of its financial results in accordance with U.S. GAAP. CTS believes that the non-GAAP financial measures presented are commonly used by financial analysts and others in the industries in which CTS operates, and thus further provide useful information to investors. CTS’ definitions of these non-GAAP financial measures may differ from those terms as defined or used by other companies. Non-GAAP measures should not be used by investors or third parties as the sole basis for formulating investment decisions, as they may exclude a number of important cash and non-cash recurring items.

CTS has presented these non-GAAP financial measures as it believes that the presentation of its financial results that exclude (1) restructuring charges; (2) restructuring-related charges; (3) environmental charges; (4) acquisition-related adjustments; (5) inventory fair value step-up costs; (6) foreign exchange (gains) losses; (7) non-cash pension expenses (income); and (8) certain discrete tax items are useful and assist in comparing CTS’ current operating results with past periods and with the operational performance of other companies in its industry. Included below is a description of the expenses that CTS has determined are not normal, recurring cash operating expenses necessary to operate its business and the rationale for why providing financial measures for its business with such expenses excluded or adjusted is useful to investors as a supplement to the U.S. GAAP measures.

•

Restructuring charges – costs primarily relating to workforce reduction costs, building and equipment relocation costs, asset impairment charges and other facility closure costs in connection with our continued optimization of our organization.

•

Restructuring-related charges – costs related to restructuring actions that do not qualify as direct restructuring charges under US GAAP. These include duplicative expenses incurred due to the plant consolidation related transition activities such as excess rent, utilities, personnel related and other costs prior to start of production at the new location.

•

Environmental charges – costs associated with our non-operating facilities that are unrelated to ongoing operations. Currently, none of these costs and accruals relate to sites that provide revenue generating activities for the Company.

•

Acquisition-related adjustments – diligence and transaction costs related to acquisitions including related contingent earnout and other adjustments.

•

Inventory fair value step-up costs – purchase accounting-related inventory costs from acquisitions.

•

Foreign exchange (gains) losses – remeasurement income and expenses for non-U.S. subsidiaries with the U.S. dollar as the functional currency.

•

Non-cash pension expenses (income) – pension income and expenses relating to the non-operating U.S. pension and post-retirement life insurance plans, including historical plan settlement activities.

•

Discrete tax items – non-recurring, infrequent, or unusual tax adjustments (e.g., valuation allowances, uncertain tax position changes, unremitted assertion changes and discrete impacts associated with pre-tax non-GAAP items or due to tax law changes, etc.).

At times, the reconciliations below have been intentionally rounded to the nearest thousand, or $0.01 for EPS figures, and, therefore, may not sum.

www.ctscorp.com

Adjusted Gross Margin

Three Months Ended

June 30,

Six Months Ended

June 30,

Twelve Months Ended

December 31,

2026

2025

2026

2025

2024

2023

Gross margin

60.0

52.4

115.0

99.0

208.0

187.6

190.9

Net sales

144.8

135.3

284.0

261.1

541.3

514.8

550.4

Gross margin as a % of net sales

41.5

38.7

40.5

37.9

38.4

36.4

34.7

Adjustments to reported gross margin:

Restructuring-related charges (b)

—

0.2

0.7

0.6

Inventory fair value step-up (b)

—

2.1

—

Adjusted gross margin

60.0

52.4

115.0

99.0

208.2

190.4

191.4

Adjusted gross margin as a % of net sales

41.5

38.7

40.5

37.9

38.5

37.0

34.8

Adjusted Operating Earnings

Three Months Ended

June 30,

Six Months Ended

June 30,

Twelve Months Ended

December 31,

2026

2025

2026

2025

2024

2023

Operating earnings

26.8

22.7

48.8

39.0

82.6

71.2

75.1

Net sales

144.8

135.3

284.0

261.1

541.3

514.8

550.4

Operating earnings as a % of net sales

18.5

16.8

17.2

14.9

15.3

13.8

13.6

Adjustments to reported operating earnings:

Restructuring charges (c)

0.1

0.3

0.5

0.7

1.4

4.7

7.1

Restructuring-related charges (b)

0.1

—

0.1

—

0.7

0.6

Environmental charges (a)

0.4

0.2

0.6

0.4

5.5

1.6

3.5

Acquisition-related adjustments (a)

0.1

(1.3

)

0.1

(1.5

)

(3.4

)

(0.3

)

0.4

Inventory fair value step-up (b)

—

2.1

—

Total adjustments to reported operating earnings

0.6

(0.8

)

1.4

(0.4

)

4.2

8.8

11.5

Adjusted operating earnings

27.4

21.9

50.1

38.6

86.9

80.0

86.6

Adjusted operating earnings as a % of net sales

18.9

16.2

17.7

14.8

16.0

15.5

15.7

Adjusted EBITDA Margin

Three Months Ended

June 30,

Six Months Ended

June 30,

Twelve Months Ended

December 31,

2026

2025

2026

2025

2024

2023

Net earnings

19.2

18.5

36.4

31.9

65.3

55.5

60.5

Net sales

144.8

135.3

284.0

261.1

541.3

514.8

550.4

Net earnings margin

13.2

13.7

12.8

12.2

12.1

10.8

11.0

Depreciation and amortization expense

8.8

8.6

17.6

17.0

34.5

30.9

28.7

Interest expense

0.7

1.1

1.4

2.3

4.3

4.2

3.3

Tax expense

7.1

4.5

11.6

7.2

18.5

13.1

14.6

EBITDA

35.7

32.7

66.9

58.4

122.6

103.7

107.2

EBITDA Margin

24.7

24.2

23.6

22.4

22.6

20.1

19.5

Adjustments to EBITDA:

Restructuring charges (c)

0.1

0.3

0.5

0.7

1.4

4.7

7.1

Restructuring-related charges (b)

0.1

—

0.1

—

0.7

0.6

Environmental charges (a)

0.4

0.2

0.6

0.4

5.5

1.6

3.5

Acquisition-related adjustments (a)

0.1

(1.3

)

0.1

(1.5

)

(5.6

)

(0.3

)

0.4

Inventory fair value step-up (b)

—

2.1

—

Non-cash pension and related expense (d)

—

0.1

0.2

—

Foreign currency loss (gain) (d)

0.4

(0.8

)

0.5

(1.3

)

(1.3

)

2.7

2.0

Total adjustments to EBITDA

1.0

(1.6

)

1.9

(1.6

)

0.9

11.7

13.5

Adjusted EBITDA

36.8

31.1

68.8

56.8

123.4

115.4

120.7

Adjusted EBITDA Margin

25.4

23.0

24.2

21.8

22.8

22.4

21.9

Adjusted Net Earnings and Adjusted Diluted Earnings Per Share

Three Months Ended

June 30,

Six Months Ended

June 30,

2026

2025

2026

2025

Per share

Net earnings (A)

19.2

0.66

18.5

0.62

36.4

1.26

31.9

1.06

Adjustments to reported net earnings:

Restructuring charges (c)

0.1

0.00

0.3

0.01

0.5

0.02

0.7

0.03

Restructuring-related charges (a)

0.1

0.00

—

0.1

0.00

—

Environmental charges (a)

0.4

0.01

0.2

0.01

0.6

0.02

0.4

0.01

Acquisition-related adjustments (a)

0.1

0.00

(1.3

)

(0.05

)

0.1

0.00

(1.5

)

(0.05

)

Non-cash pension and related expense (d)

—

0.1

—

Foreign currency loss (gain) (d)

0.4

0.01

(0.8

)

(0.03

)

0.5

0.02

(1.3

)

(0.04

)

Total pretax adjustments to reported net earnings

1.0

0.04

(1.6

)

(0.06

)

1.9

0.06

(1.6

)

(0.05

)

Income tax effect of above adjustments (f)

(0.1

)

(0.00

)

0.3

0.01

(0.3

)

(0.01

)

0.1

—

Total adjustments, tax affected (f) (B)

0.9

0.03

(1.3

)

(0.05

)

1.6

0.05

(1.5

)

(0.05

)

Tax adjustments:

Other discrete tax items (e)

1.3

0.04

0.1

—

1.3

0.04

0.1

—

Total tax adjustments (C)

1.3

0.04

0.1

—

1.3

0.04

0.1

—

Adjusted net earnings (A+B+C) and Adjusted net earnings per share

21.3

0.74

17.3

0.57

39.2

1.35

30.5

1.01

Net sales

144.8

135.3

284.0

261.1

Net earnings as a % of net sales

13.2

13.7

12.8

12.2

Adjusted net earnings as a % of net sales

14.7

12.8

13.8

11.7

Twelve Months Ended

December 31,

2025

2024

2023

Per share

Net earnings (A)

65.3

2.19

55.5

1.80

60.5

1.92

Adjustments to reported net earnings:

Restructuring charges (c)

1.4

0.05

4.7

0.15

7.1

0.22

Restructuring-related charges (a)

0.7

0.02

0.7

0.02

0.6

0.02

Environmental charges (a)

5.5

0.18

1.6

0.05

3.5

0.11

Acquisition-related adjustments (a)

(5.6

)

(0.19

)

(0.3

)

(0.01

)

0.4

0.01

Inventory fair value step-up (b)

—

2.1

0.07

—

Non-cash pension and related expense (d)

0.1

0.00

0.2

0.01

—

Foreign currency (gain) loss (d)

(1.3

)

(0.04

)

2.7

0.09

2.0

0.06

Total pretax adjustments to reported net earnings

0.9

0.03

11.7

0.38

13.5

0.42

Income tax effect of above adjustments (f)

(0.6

)

(0.02

)

(2.2

)

(0.07

)

(2.4

)

(0.07

)

Total adjustments, tax affected (f) (B)

0.3

0.01

9.5

0.31

11.1

0.35

Tax adjustments:

Increase in valuation allowances (e)

—

Other discrete tax items (e)

0.8

0.03

0.3

0.01

(1.6

)

(0.05

)

Total tax adjustments (C)

0.8

0.03

0.3

0.01

(1.6

)

(0.05

)

Adjusted net earnings (A+B+C) and Adjusted net earnings per share

66.3

2.23

65.3

2.12

70.0

2.22

Net sales

541.3

514.8

550.4

Net earnings as a % of net sales

12.1

10.8

11.0

Adjusted net earnings as a % of net sales

12.3

12.7

(a) Reflected in Selling, general and administrative and other income (expense), net.

(b) Reflected in Cost of goods sold.

(d) Reflected in Other income (expense), net.

(e) Reflected in Income tax expense. For 2023, discrete tax items include adjusting for tax benefits resulting from $0.6 million for research and development tax credits from prior years, $0.8 million in foreign tax credits related to prior years from a 2023 tax law change, as well as $0.2 million from the release of uncertain tax benefits. For 2024, the discrete tax items relate to items we deemed outside normal cash-generating operations including the addition of a valuation allowance for a foreign subsidiary. For 2025, the discrete tax items relate to items we deemed outside normal cash-generating operations including the addition of a valuation allowance for research and developmental credits and the tax impacts of an immaterial correction of a prior period error. For 2026, the discrete tax items relate to items we deemed outside normal cash-generating operations including the addition of a valuation allowance for foreign tax credits and adjustments related to uncertain tax positions.

(f) We determine the tax effect of non-GAAP adjustments by considering the tax laws and statutory income tax rates applicable in the tax jurisdictions of the underlying non-GAAP adjustments. For all periods presented, we applied the statutory income tax rates to the taxable portion of all of our adjustments. Our acquisition costs and foreign currency gains and losses included in our non-GAAP adjustments were not deductible for income tax purposes; therefore, no statutory income tax rate was applied to such costs.

NOTE: CTS believes that adjusted gross margin, adjusted operating earnings, adjusted EBITDA margin, adjusted net earnings and adjusted diluted earnings per share provide useful information to investors regarding its operational performance because they enhance an investor’s overall understanding of CTS’ core financial performance and facilitate comparisons to historical results of operations, by excluding items that are not related directly to the underlying performance of CTS’ fundamental business operations (such as those items noted above in the paragraph titled “Non-GAAP Financial Measures”) or were not part of CTS’ business operations during a comparable period.

Controllable Working Capital

June 30,

December 31,

2026

2025

2024

2023

Net accounts receivable

92.2

85.6

88.1

77.6

78.6

Net inventory

59.6

57.1

52.9

52.3

60.0

Accounts payable

(50.0

)

(47.3

)

(48.2

)

(42.6

)

(43.5

)

Controllable working capital

101.8

95.4

92.7

87.3

95.1

Quarter sales

144.8

135.3

137.3

126.4

124.7

Multiplied by 4

Annualized sales

579.1

541.2

549.1

505.6

498.8

Controllable working capital as a % of annualized sales

17.6

16.9

17.3

19.1

NOTE: CTS believes the controllable working capital ratio is a useful measure because it provides an objective measure of the efficiency with which CTS manages its short-term capital needs.

Free Cash Flow

Three Months Ended

June 30,

Six Months Ended

June 30,

Twelve Months Ended

December 31,

2026

2025

2026

2025

2024

2023

Net cash provided by operating activities

33.4

28.4

50.7

43.9

102.1

98.2

88.8

Capital expenditures

(4.6

)

(3.3

)

(9.6

)

(7.7

)

(15.7

)

(18.6

)

(14.7

)

Free cash flow

28.8

25.1

41.1

36.2

86.4

79.6

74.1

Operating cash flow as a percentage of net earnings

174

153

139

138

156

177

147

Free cash flow as a percentage of adjusted net earnings

135

145

105

119

130

122

106

NOTE: CTS believes that free cash flow is a useful measure because it demonstrates the company’s ability to generate cash. Free cash flow is a non-GAAP measure and should be considered in addition to, but not as a substitute for, information contained in the company's condensed consolidated statement of cash flows as a measure of liquidity.

Capital Expenditures

Three Months Ended

June 30,

Six Months Ended

June 30,

Twelve Months Ended

December 31,

2026

2025

2026

2025

2024

2023

Capital expenditures

4.6

3.3

9.6

7.7

15.7

18.6

14.7

Net sales

144.8

135.3

284.0

261.1

541.3

514.8

550.4

Capex as % of net sales

3.2

2.4

3.4

2.9

3.6

2.7

Additional Information

The following table includes other financial information not presented in the preceding financial statements.

Three Months Ended

June 30,

Six Months Ended

June 30,

Twelve Months Ended

December 31,

2026

2025

2026

2025

2024

2023

Depreciation and amortization expense

8.8

8.6

17.6

17.0

34.5

30.9

28.7

Stock-based compensation expense

2.0

0.6

4.0

2.3

4.9

5.7

5.2

EX-99.2

Filename: cts-ex99_2.htm · Sequence: 3

CTS Corporation 2nd Quarter 2026 Earnings Call July 28, 2026

Cautionary Statement Regarding Forward-Looking Statements Readers are cautioned that the statements contained in this document regarding expectations of our performance or other matters that may affect our business, results of operations, or financial condition are, or may be deemed to be, “forward-looking statements” as defined by the “safe harbor” provisions in the Private Securities Litigation Reform Act of 1995. Such statements are made in reliance on the safe harbor provisions of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All statements, other than statements of historical fact, included or incorporated in this document, including statements regarding our strategy, financial position, guidance, funding for continued operations, cash reserves, liquidity, projected costs, plans, projects, awards and contracts, and objectives of management, among others, are forward-looking statements. Words such as “expect,” “anticipate,” “should,” “believe,” “hope,” “target,” “continued,” “project,” “plan,” “goals,” “opportunity,” “appeal,” “estimate,” “potential,” “predict,” “demonstrates,” “may,” “will,” “might,” “could,” “intend,” “shall,” “possible,” “would,” “approximately,” “likely,” “outlook,” “schedule,” “on track,” “poised,” “pipeline,” and variations of these terms or the negative of these terms and similar expressions are intended to identify these forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. These forward-looking statements are not guarantees of future performance, conditions or results. Forward-looking statements are based on management’s expectations, certain assumptions, and currently available information. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof and are based on various assumptions as to future events, the occurrence of which necessarily are subject to uncertainties. These forward-looking statements are made subject to certain risks, uncertainties, and other factors, which could cause CTS’ actual results, performance, or achievements to differ materially from those presented in the forward-looking statements. Examples of factors that may affect future operating results and financial condition include, but are not limited to: supply chain disruptions (including, but not limited to, the availability and cost of rare earth elements, minerals and metals); changes in the economy generally, including inflationary and/or recessionary conditions and increased tariffs, and in respect to the businesses in which CTS operates; unanticipated issues in integrating acquisitions; the funding of contracts by the U.S. Government; the results of actions to reposition CTS’ business; rapid technological change; general market conditions in the transportation, as well as conditions in the industrial, aerospace and defense, and medical markets; reliance on key customers; unanticipated public health crises, natural disasters or other events; environmental compliance and remediation expenses; the ability to protect CTS’ intellectual property; pricing pressures and demand for CTS’ products; risks associated with CTS’ international operations, including trade and tariff barriers, trade pacts, including the future of the USMCA, exchange rates and political and geopolitical risks (including, without limitation, the impact of tariffs on China, Canada and Mexico, and other nations, the potential impact of U.S./China relations and the impact of geopolitical conflicts may have on our business, results of operations and financial condition; write offs of goodwill on our balance sheet; the amount and timing of any share repurchases; and the effect of any cybersecurity incidents on our business. Many of these, and other risks and uncertainties, are discussed in further detail in Item 1A. of CTS's most recent Annual Report on Form 10-K and other filings made with the SEC. CTS undertakes no obligation to publicly update CTS’ forward-looking statements to reflect new information or events or circumstances that arise after the date hereof, including market or industry changes. CTS refers to the forward-looking measures of book-to-bill ratio and total booked business in this document. Book-to-bill ratio is the ratio of customer orders received to revenues recorded for the same period. Although the book-to-bill ratio reflects firm customer orders, changes such as terminations, amendments, or contract cancellations may occur which could result in a reduction to the customer orders. Total booked business reflects expected revenue from the remaining life of long-term agreements with transportation customers. Total booked business is adjusted periodically for changes in expected revenue based on market information, fluctuations in foreign currency exchange rates, information from our customers, and any other factors that may impact the expected revenue from these agreements. Book-to-bill ratio and total booked business are not defined by U.S. GAAP and our methodology for calculating these measures may not be consistent with or comparable to other similarly titled measures of other companies.

Solid execution in Q2 Revenue increased 7% YoY and 4% Vs Q1 2026 Book-to-bill ratio2 of 1.1 Adj. gross margin expanded 270 bps Continued momentum in diversified end markets 15% Revenue growth Diversified end markets 59% of Q2 2026 revenue Strong bookings – Book-to-bill ratio2 1.17 Transportation end market Revenue modestly declined – (2)% in Q2 2026 Large sensor award with a North American OEM Notes: All comparisons vs. same period in prior year unless otherwise noted. 1 Adj. Gross Margin and Adj. Earnings per Share are non-GAAP financial measures. Refer to the Appendix for reconciliations of non-GAAP financial measures to the most directly comparable financial measures calculated and presented in accordance with GAAP. 2 Refer to slide 2 for information on book-to-bill ratio. Q2 2026 – Strong Diversification Momentum Drives Record Margins and Profitability $145M Revenue +7% Second Quarter 41.5% Adj. Gross Margin1 +270 bps $0.74 Adj. Diluted EPS1 +$0.17

Medical 4 Aerospace & Defense End Markets Update ($ Millions) Revenue ($ Millions) Revenue Q2 sales up 45% Vs Q2 2025; 14% Vs Q1 2026 Book‑to‑bill 1.21, bookings up 14% vs Q2 2025 Strong partnership with customers for next-generation product development Sustained strong demand for diagnostics and therapeutic products Q2 sales down 15% Vs Q2 2025 due to timing of contract awards; up 4% Vs Q1 2026 Strong Book‑to‑bill 1.23, bookings up 48% vs. Q2 2025 Added a new customer in defense satellite communication for RF filter products

End Markets Update 5 Industrial Q2 sales up 16% Vs Q2 2025; 6% Vs Q1 2026 Strong bookings - Book-to-bill ratio 1.11 Solid momentum across diverse set of applications Added 2 new customers ($ Millions) Revenue 1 Refer to slide 2 for information on total booked business. Transportation Q2 sales down 2% year over year $1.2b total booked business1 at end of Q2 2026 – $163m in new wins in the quarter Significant award with a North American OEM for a sensing application Added a new EV customer ($ Millions) Revenue

$2.70 $2.55 Notes: 1 Adjusted Diluted EPS is a non-GAAP financial measure. Refer to the Appendix for reconciliations of non-GAAP financial measures to the most directly comparable financial measures calculated and presented in accordance with GAAP. FY 2026 Updated Guidance Revenue ($ Millions) Adjusted Diluted EPS 1 $565 $585 Continuation of current market conditions – Ongoing monitoring of near‑term economic impacts, including geopolitical conflicts, tariff changes, precious metals, and petroleum‑based products, with a focus on agility in cost and pricing actions Continued progress on growth in diversified end markets Light vehicle production expected to be flat to slightly down, partially offset by commercial vehicle volumes Effective tax rate expected to be in the range of 21–23%, excluding discrete items Key Outlook Assumptions

Financials

Notes: All comparisons vs. same period in prior year unless otherwise noted. 1 Adj. Diluted EPS, Adj. Gross Margin and Adj. EBITDA Margin are non-GAAP financial measures. Refer to the Appendix for reconciliations of non-GAAP financial measures to the most directly comparable financial measures calculated and presented in accordance with GAAP. Revenue up 7% year over year and 4% sequentially; $1.4m currency benefit in the quarter Diversified end market revenue up 15% vs Q2 2025 Transportation revenue down 2% year-over-year Adjusted gross margin +270 bps vs. Q2 2025, driven by operations, mix, and FX benefit Adjusted EBITDA up 240 bps vs Q2 2025 Monitoring USMCA, tariff changes, metals/oil inflation Q2 2026 FX favorability and customer reimbursements added $0.07 to EPS Net Income $18.5 $17.2 $19.2 Diluted EPS $0.62 $0.59 $0.66 Adj. Diluted EPS1 $0.57 $0.62 $0.74 Adj. Gross Margin1 38.7% 39.5% 41.5% Adj. EBITDA Margin1 23.0% 23.0% 25.4% Revenue Q2 2026 Financial Summary Results ($ Millions, except percentages and per share amounts) Highlights

Cash and Debt1 $15M Cash Returned to Shareholders YTD Q2 20263 $41M YTD Q2 2026 Free Cash Flow2 Strong Balance Sheet Solid Foundation for Strategic M&A $10M YTD Q2 2026 Capital Expenditures Borrowed Total Facility Q2 YTD Operating Cash Flow Prioritizing strong cash flow generation ($ Millions) ($ Millions) Notes: 1 Cash and Debt balance as of June 30, 2026 2 Free Cash Flow is a non-GAAP financial measure. Refer to the Appendix for reconciliations of non-GAAP financial measures to the most directly comparable financial measures calculated and presented in accordance with GAAP. 3 Cash Returned to Shareholders consists of share repurchases & dividends.

Q & A

Appendix

Non-GAAP Financial Measures From time to time, CTS may use non-GAAP financial measures in discussing CTS’ business. These measures are intended to supplement, not replace, CTS’ presentation of its financial results in accordance with U.S. GAAP. CTS believes that the non-GAAP financial measures presented are commonly used by financial analysts and others in the industries in which CTS operates, and thus further provide useful information to investors. CTS’ definitions of these non-GAAP financial measures may differ from those terms as defined or used by other companies. Non-GAAP measures should not be used by investors or third parties as the sole basis for formulating investment decisions, as they may exclude a number of important cash and non-cash recurring items. CTS has presented these non-GAAP financial measures as it believes that the presentation of its financial results that exclude (1) restructuring charges; (2) restructuring-related charges; (3) environmental charges; (4) acquisition-related adjustments; (5) inventory fair value step-up costs; (6) foreign exchange (gains) losses; (7) non-cash pension expenses (income); and (8) certain discrete tax items are useful and assist in comparing CTS’ current operating results with past periods and with the operational performance of other companies in its industry. Included below is a description of the expenses that CTS has determined are not normal, recurring cash operating expenses necessary to operate its business and the rationale for why providing financial measures for its business with such expenses excluded or adjusted is useful to investors as a supplement to the U.S. GAAP measures. Restructuring charges – costs primarily relating to workforce reductions, building and equipment relocations, asset impairment charges and other facility closure activities in connection with our continued optimization of our organization. Restructuring-related charges – costs related to restructuring actions that do not qualify as direct restructuring charges under U.S. GAAP. These include duplicative expenses incurred due to plant consolidation related transition activities such as excess rent, utilities, personnel related and other costs incurred prior to the start of production at the new location. Environmental charges – costs associated with our non-operating facilities that are unrelated to ongoing operations. Currently, none of these costs and accruals relate to sites that provide revenue generating activities for the Company. Acquisition-related adjustments – diligence and transaction costs related to acquisitions including related contingent earnout and other adjustments. Inventory fair value step-up costs – purchase accounting-related inventory costs from acquisitions. Foreign exchange (gains) losses – remeasurement income and expenses for non-U.S. subsidiaries with the U.S. dollar as the functional currency. Non-cash pension expenses (income) – pension income and expenses relating to the non-operating U.S. pension and post-retirement life insurance plans, including historical plan settlement activities. Discrete tax items – non-recurring, infrequent, or unusual tax adjustments (e.g., valuation allowances, uncertain tax position changes, unremitted assertion changes and discrete impacts associated with pre-tax non-GAAP items or due to tax law changes, etc.). At times, the reconciliations below have been intentionally rounded to the nearest thousand, or $0.01 for EPS figures, and, therefore, may not sum. CTS does not provide reconciliations of forward-looking non-GAAP financial measures, such as estimated adjusted diluted earnings per share, to the most comparable GAAP financial measures on a forward-looking basis because CTS is unable to provide a meaningful or accurate calculation or estimation of reconciling items and the information is not available without unreasonable effort. This is due to the inherent difficulty of forecasting the timing and amount of certain items, such as, but not limited to, restructuring costs, environmental remediation costs, acquisition-related costs, foreign exchange rates and other non-routine costs. Each of such adjustments has not yet occurred, are out of CTS' control and/or cannot be reasonably predicted. For the same reasons, CTS is unable to address the probable significance of the unavailable information.

Regulation G Schedules ($ Millions, except percentages) Adjusted Gross Margin Three Months EndedJune 30, Six Months EndedJune 30, Three Months Ended March 31, Twelve Months EndedDecember 31, 2026 2025 2026 2025 2026 2025 2024 2023 Gross margin $ 60.0 $ 52.4 $ 115.0 $ 99.0 $ 55.0 $ 208.0 $ 187.6 $ 190.9 Net sales $ 144.8 $ 135.3 $ 284.0 $ 261.1 $ 139.2 $ 541.3 $ 514.8 $ 550.4 Gross margin as a % of net sales 41.5% 38.7% 40.5% 37.9% 39.5% 38.4% 36.4% 34.7% Adjustments to reported gross margin: Restructuring-related charges (b) — — — — — 0.2 0.7 0.6 Inventory fair value step-up (b) — — — — — — 2.1 — Adjusted gross margin $ 60.0 $ 52.4 $ 115.0 $ 99.0 $ 55.0 $ 208.2 $ 190.4 $ 191.4 Adjusted gross margin as a % of net sales 41.5% 38.7% 40.5% 37.9% 39.5% 38.5% 37.0% 34.8%

Regulation G Schedules ($ Millions, except percentages) Adjusted Operating Earnings Three Months EndedJune 30, Six Months EndedJune 30, Twelve Months EndedDecember 31, 2026 2025 2026 2025 2025 2024 2023 Operating earnings $ 26.8 $ 22.7 $ 48.8 $ 39.0 $ 82.6 $ 71.2 $ 75.1 Net sales $ 144.8 $ 135.3 $ 284.0 $ 261.1 $ 541.3 $ 514.8 $ 550.4 Operating earnings as a % of net sales 18.5% 16.8% 17.2% 14.9% 15.3% 13.8% 13.6% Adjustments to reported operating earnings: Restructuring charges (c) 0.1 0.3 0.5 0.7 1.4 4.7 7.1 Restructuring-related charges (b) 0.1 — 0.1 — 0.7 0.7 0.6 Environmental charges (a) 0.4 0.2 0.6 0.4 5.5 1.6 3.5 Acquisition-related adjustments (a) 0.1 (1.3) 0.1 (1.5) (3.4) (0.3) 0.4 Inventory fair value step-up (b) — — — — — 2.1 — Total adjustments to reported operating earnings $ 0.6 $ (0.8) $ 1.4 $ (0.4) $ 4.2 $ 8.8 $ 11.5 Adjusted operating earnings $ 27.4 $ 21.9 $ 50.1 $ 38.6 $ 86.9 $ 80.0 $ 86.6 Adjusted operating earnings as a % of net sales 18.9% 16.2% 17.7% 14.8% 16.0% 15.5% 15.7%

Regulation G Schedules ($ Millions, except percentages) Adjusted EBITDA Margin Three Months EndedJune 30, Six Months EndedJune 30, Three Months Ended March 31, Twelve Months EndedDecember 31, 2026 2025 2026 2025 2026 2025 2024 2023 Net earnings $ 19.2 $ 18.5 $ 36.4 $ 31.9 $ 17.2 $ 65.3 $ 55.5 $ 60.5 Net sales $ 144.8 $ 135.3 $ 284.0 $ 261.1 $ 139.2 $ 541.3 $ 514.8 $ 550.4 Net earnings margin 13.2% 13.7% 12.8% 12.2% 12.4% 12.1% 10.8% 11.0% Depreciation and amortization expense 8.8 8.6 17.6 17.0 8.8 34.5 30.9 28.7 Interest expense 0.7 1.1 1.4 2.3 0.7 4.3 4.2 3.3 Tax expense 7.1 4.5 11.6 7.2 4.5 18.5 13.1 14.6 EBITDA 35.7 32.7 66.9 58.4 31.2 122.6 103.7 107.2 EBITDA Margin 24.7% 24.2% 23.6% 22.4% 22.4% 22.6% 20.1% 19.5% Adjustments to EBITDA: Restructuring charges (c) 0.1 0.3 0.5 0.7 0.4 1.4 4.7 7.1 Restructuring-related charges (b) 0.1 — 0.1 — 0.1 0.7 0.7 0.6 Environmental charges (a) 0.4 0.2 0.6 0.4 0.2 5.5 1.6 3.5 Acquisition-related adjustments (a) 0.1 (1.3) 0.1 (1.5) 0.1 (5.6) (0.3) 0.4 Inventory fair value step-up (b) — — — — — — 2.1 — Non-cash pension and related expense (d) — — — 0.1 — 0.1 0.2 — Foreign currency loss (gain) (d) 0.4 (0.8) 0.5 (1.3) 0.1 (1.3) 2.7 2.0 Total adjustments to EBITDA 1.0 (1.6) 1.9 (1.6) 0.8 0.9 11.7 13.5 Adjusted EBITDA $ 36.8 $ 31.1 $ 68.8 $ 56.8 $ 32.0 $ 123.4 $ 115.4 $ 120.7 Adjusted EBITDA Margin 25.4% 23.0% 24.2% 21.8% 23.0% 22.8% 22.4% 21.9%

Regulation G Schedules ($ Millions, except percentages and per share amounts) Adjusted Net Earnings and Adjusted Diluted Earnings Per Share Three Months EndedJune 30, Six Months EndedJune 30, Three Months Ended March 31, 2026 2026 2025 2025 2026 2026 2025 2025 2026 2026 Per Share Per Share Per share Per share Per share Net earnings (A) $ 19.2 $ 0.66 $ 18.5 $ 0.62 $ 36.4 $ 1.26 $ 31.9 $ 1.06 $ 17.2 $ 0.59 Adjustments to reported net earnings: Restructuring charges (c) 0.1 0.00 0.3 0.01 0.5 0.02 0.7 0.03 0.4 0.01 Restructuring related charges (a) 0.1 0.00 — — 0.1 0.00 — — 0.1 — Environmental charges (a) 0.4 0.01 0.2 0.01 0.6 0.02 0.4 0.01 0.2 0.01 Acquisition-related adjustments (a) 0.1 0.00 (1.3) (0.05) 0.1 0.00 (1.5) (0.05) 0.1 — Non-cash pension and related expense (d) — — — — — — — — — — Foreign currency loss (gain) (d) 0.4 0.01 (0.8) (0.03) 0.5 0.02 (1.3) (0.04) 0.1 — Total pretax adjustments to reported net earnings $ 1.0 $ 0.04 $ (1.6) $ (0.06) $ 1.9 $ 0.06 $ (1.6) $ (0.05) $ 0.8 $ 0.03 Income tax effect of above adjustments (f) (0.1) (0.00) 0.3 0.01 (0.3) (0.01) 0.1 — (0.2) 0.01 Total adjustments, tax affected (f) (B) $ 0.9 $ 0.03 $ (1.3) $ (0.05) $ 1.6 $ 0.05 $ (1.5) $ (0.05) $ 0.7 $ (0.02) Tax adjustments: Other discrete tax items (e) 1.3 0.04 0.1 — 1.3 0.04 0.1 — — — Total tax adjustments (C) $ 1.3 $ 0.04 $ 0.1 $ — $ 1.3 $ 0.04 $ 0.1 $ — $ — $ — Adjusted net earnings (A+B+C) and Adjusted net earnings per share $ 21.3 $ 0.74 $ 17.3 $ 0.57 $ 39.2 $ 1.35 $ 30.5 $ 1.01 $ 17.9 $ 0.62 Net sales $ 144.8 $ 135.3 $ 284.0 $ 261.1 $ 139.2 Net earnings as a % of net sales 13.2% 13.7% 12.8% 12.2% 12.4% Adjusted net earnings as a % of net sales 14.7% 12.8% 13.8% 11.7% 12.8%

Regulation G Schedules ($ Millions, except percentages and per share amounts) Adjusted Net Earnings and Adjusted Diluted Earnings Per Share NOTE: CTS believes that adjusted gross margin, adjusted operating earnings, adjusted EBITDA margin, adjusted net earnings and adjusted diluted earnings per share provide useful information to investors regarding its operational performance because they enhance an investor’s overall understanding of CTS’ core financial performance and facilitate comparisons to historical results of operations, by excluding items that are not related directly to the underlying performance of CTS’ fundamental business operations (such as those items noted above in the paragraph titled “Non-GAAP Financial Measures”) or were not part of CTS’ business operations during a comparable period. Twelve Months EndedDecember 31, 2025 2025 2024 2024 2023 2023 Per share Per share Per share Net earnings (loss) (A) $ 65.3 $ 2.19 $ 55.5 $ 1.80 $ 60.5 $ 1.92 Adjustments to reported net earnings (loss): Restructuring charges (c) 1.4 0.05 4.7 0.15 7.1 0.22 Restructuring related charges (a) 0.7 0.02 0.7 0.02 0.6 0.02 Environmental charges (a) 5.5 0.18 1.6 0.05 3.5 0.11 Acquisition-related adjustments (a) (5.6) (0.19) (0.3) (0.01) 0.4 0.01 Inventory fair value step-up (b) — — 2.1 0.07 — — Non-cash pension and related expense (d) 0.1 0.00 0.2 0.01 — — Foreign currency (gain) loss (d) (1.3) (0.04) 2.7 0.09 2.0 0.06 Total pretax adjustments to reported net earnings (loss) $ 0.9 $ 0.03 $ 11.7 $ 0.38 $ 13.5 $ 0.42 Income tax effect of above adjustments (f) (0.6) (0.02) (2.2) (0.07) (2.4) (0.07) Total adjustments, tax affected (f) (B) $ 0.3 $ 0.01 $ 9.5 $ 0.31 $ 11.1 $ 0.35 Tax adjustments: Increase in valuation allowances (e) — — — — — — Other discrete tax items (e) 0.8 0.03 0.3 0.01 (1.6) (0.05) Total tax adjustments (C) $ 0.8 $ 0.03 $ 0.3 $ 0.01 $ (1.6) $ (0.05) Adjusted net earnings (A+B+C) and Adjusted Net Earnings Per Share $ 66.3 $ 2.23 $ 65.3 $ 2.12 $ 70.0 $ 2.22 Net sales $ 541.3 $ 514.8 $ 550.4 Net earnings (loss) as a % of net sales 12.1% 10.8% 11.0% Adjusted net earnings as a % of net sales 12.3% 12.7% 12.7%

Reflected in Selling, general and administrative and other income (expense), net. Reflected in Cost of goods sold. Reflected in Restructuring charges. Reflected in Other income (expense), net. Reflected in Income tax expense. For 2023, discrete tax items include adjusting for tax benefits resulting from $0.6 million for research and development tax credits from prior years, $0.8 million in foreign tax credits related to prior years from a 2023 tax law change, as well as $0.2 million from the release of uncertain tax benefits. For 2024, the discrete tax items relate to items we deemed outside normal cash-generating operations including the addition of a valuation allowance for a foreign subsidiary. For 2025, the discrete tax items relate to items we deemed outside normal cash-generating operations including the addition of a valuation allowance for research and developmental credits and the tax impacts of an immaterial correction of a prior period error. For 2026, the discrete tax items relate to items we deemed outside normal cash-generating operations including the addition of a valuation allowance for foreign tax credits and adjustments related to uncertain tax positions. We determine the tax effect of non-GAAP adjustments by considering the tax laws and statutory income tax rates applicable in the tax jurisdictions of the underlying non-GAAP adjustments. For all periods presented, we applied the statutory income tax rates to the taxable portion of all of our adjustments. Our acquisition costs and foreign currency gains and losses included in our non-GAAP adjustments were not deductible for income tax purposes; therefore, no statutory income tax rate was applied to such costs. Regulation G Schedules

($ Millions, except percentages) Free Cash Flow ($ Millions, except percentages) Controllable Working Capital NOTE: CTS believes the controllable working capital ratio is a useful measure because it provides an objective measure of the efficiency with which CTS manages its short-term capital needs. NOTE: CTS believes that free cash flow is a useful measure because it demonstrates the company’s ability to generate cash. Free cash flow is a non-GAAP measure and should be considered in addition to, but not as a substitute for, information contained in the company's condensed consolidated statement of cash flows as a measure of liquidity. Regulation G Schedules Three Months EndedJune 30, Twelve Months EndedDecember 31, 2026 2025 2025 2024 2023 Net accounts receivable $ 92.2 $ 85.6 $ 88.1 $ 77.6 $ 78.6 Net inventory $ 59.6 $ 57.1 $ 52.9 $ 52.3 $ 60.0 Accounts payable $ (50.0) $ (47.3) $ (48.2) $ (42.6) $ (43.5) Controllable working capital $ 101.8 $ 95.4 $ 92.7 $ 87.3 $ 95.1 Quarter sales $ 144.8 $ 135.3 $ 137.3 $ 126.4 $ 124.7 Multiplied by 4 4 4 4 4 4 Annualized sales $ 579.1 $ 541.2 $ 549.1 $ 505.6 $ 498.8 Controllable working capital as a % of annualized sales 17.6% 17.6% 16.9% 17.3% 19.1% Three Months EndedJune 30, Six Months EndedJune 30, Twelve Months EndedDecember 31, 2026 2025 2026 2025 2025 2024 2023 Net cash provided by operating activities $ 33.4 $ 28.4 $ 50.7 $ 43.9 $ 102.1 $ 98.2 $ 88.8 Capital expenditures (4.6) (3.3) (9.6) (7.7) (15.7) (18.6) (14.7) Free cash flow $ 28.8 $ 25.1 $ 41.1 $ 36.2 $ 86.4 $ 79.6 $ 74.1 Operating cash flow as a percentage of net earnings 174% 153% 139% 138% 156% 177% 147% Operating cash flow as a percentage of adjusted EBITDA 91% 91% 74% 77% 83% 85% 74% Free cash flow as a percentage of adjusted net earnings 135% 145% 105% 119% 130% 122% 106%

GRAPHIC

Filename: img192797187_0.jpg · Sequence: 4

Binary file (3824 bytes)

Download img192797187_0.jpg

GRAPHIC

Filename: cts-ex99_2s1.jpg · Sequence: 5

Binary file (299650 bytes)

Download cts-ex99_2s1.jpg

GRAPHIC

Filename: cts-ex99_2s2.jpg · Sequence: 6

Binary file (708218 bytes)

Download cts-ex99_2s2.jpg

GRAPHIC

Filename: cts-ex99_2s3.jpg · Sequence: 7

Binary file (291510 bytes)

Download cts-ex99_2s3.jpg

GRAPHIC

Filename: cts-ex99_2s4.jpg · Sequence: 8

Binary file (368331 bytes)

Download cts-ex99_2s4.jpg

GRAPHIC

Filename: cts-ex99_2s5.jpg · Sequence: 9

Binary file (356965 bytes)

Download cts-ex99_2s5.jpg

GRAPHIC

Filename: cts-ex99_2s6.jpg · Sequence: 10

Binary file (266685 bytes)

Download cts-ex99_2s6.jpg

GRAPHIC

Filename: cts-ex99_2s7.jpg · Sequence: 11

Binary file (94956 bytes)

Download cts-ex99_2s7.jpg

GRAPHIC

Filename: cts-ex99_2s8.jpg · Sequence: 12

Binary file (286087 bytes)

Download cts-ex99_2s8.jpg

GRAPHIC

Filename: cts-ex99_2s9.jpg · Sequence: 13

Binary file (255183 bytes)

Download cts-ex99_2s9.jpg

GRAPHIC

Filename: cts-ex99_2s10.jpg · Sequence: 14

Binary file (88324 bytes)

Download cts-ex99_2s10.jpg

GRAPHIC

Filename: cts-ex99_2s11.jpg · Sequence: 15

Binary file (91879 bytes)

Download cts-ex99_2s11.jpg

GRAPHIC

Filename: cts-ex99_2s12.jpg · Sequence: 16

Binary file (592440 bytes)

Download cts-ex99_2s12.jpg

GRAPHIC

Filename: cts-ex99_2s13.jpg · Sequence: 17

Binary file (214233 bytes)

Download cts-ex99_2s13.jpg

GRAPHIC

Filename: cts-ex99_2s14.jpg · Sequence: 18

Binary file (238380 bytes)

Download cts-ex99_2s14.jpg

GRAPHIC

Filename: cts-ex99_2s15.jpg · Sequence: 19

Binary file (295034 bytes)

Download cts-ex99_2s15.jpg

GRAPHIC

Filename: cts-ex99_2s16.jpg · Sequence: 20

Binary file (308802 bytes)

Download cts-ex99_2s16.jpg

GRAPHIC

Filename: cts-ex99_2s17.jpg · Sequence: 21

Binary file (359617 bytes)

Download cts-ex99_2s17.jpg

GRAPHIC

Filename: cts-ex99_2s18.jpg · Sequence: 22

Binary file (327358 bytes)

Download cts-ex99_2s18.jpg

GRAPHIC

Filename: cts-ex99_2s19.jpg · Sequence: 23

Binary file (338935 bytes)

Download cts-ex99_2s19.jpg

XML — IDEA: XBRL DOCUMENT

XML

Filename: R1.htm · Sequence: 26

v3.26.1

Document And Entity Information

Jul. 28, 2026

Cover [Abstract]

Document Type

8-K

Amendment Flag

false

Document Period End Date

Jul. 28, 2026

Entity Registrant Name

CTS CORPORATION

Entity Central Index Key

0000026058

Entity Emerging Growth Company

false

Entity File Number

1-4639

Entity Incorporation, State or Country Code

Entity Tax Identification Number

35-0225010

Entity Address, Address Line One

4925 Indiana Avenue

Entity Address, City or Town

Lisle

Entity Address, State or Province

Entity Address, Postal Zip Code

60532

City Area Code

(630)

Local Phone Number

577-8800

Written Communications

false

Soliciting Material

false

Pre-commencement Tender Offer

false

Pre-commencement Issuer Tender Offer

false

Title of 12(b) Security

Common Stock, no par value

Trading Symbol

CTS

Security Exchange Name

NYSE

- Definition

Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.

+ References

No definition available.

+ Details

Name:

dei_AmendmentFlag

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Area code of city

+ References

No definition available.

+ Details

Name:

dei_CityAreaCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Cover page.

+ References

No definition available.

+ Details

Name:

dei_CoverAbstract

Namespace Prefix:

dei_

Data Type:

xbrli:stringItemType

Balance Type:

Period Type:

duration

- Definition

For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.

+ References

No definition available.

+ Details

Name:

dei_DocumentPeriodEndDate

Namespace Prefix:

dei_

Data Type:

xbrli:dateItemType

Balance Type:

Period Type:

duration

- Definition

The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.

+ References

No definition available.

+ Details

Name:

dei_DocumentType

Namespace Prefix:

dei_

Data Type:

dei:submissionTypeItemType

Balance Type:

Period Type:

duration

- Definition

Address Line 1 such as Attn, Building Name, Street Name

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine1

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the City or Town

+ References

No definition available.

+ Details

Name:

dei_EntityAddressCityOrTown

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Code for the postal or zip code

+ References

No definition available.

+ Details

Name:

dei_EntityAddressPostalZipCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the state or province.

+ References

No definition available.

+ Details

Name:

dei_EntityAddressStateOrProvince

Namespace Prefix:

dei_

Data Type:

dei:stateOrProvinceItemType

Balance Type:

Period Type:

duration

- Definition

A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityCentralIndexKey

Namespace Prefix:

dei_

Data Type:

dei:centralIndexKeyItemType

Balance Type:

Period Type:

duration

- Definition

Indicate if registrant meets the emerging growth company criteria.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityEmergingGrowthCompany

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.

+ References

No definition available.

+ Details

Name:

dei_EntityFileNumber

Namespace Prefix:

dei_

Data Type:

dei:fileNumberItemType

Balance Type:

Period Type:

duration

- Definition

Two-character EDGAR code representing the state or country of incorporation.

+ References

No definition available.

+ Details

Name:

dei_EntityIncorporationStateCountryCode

Namespace Prefix:

dei_

Data Type:

dei:edgarStateCountryItemType

Balance Type:

Period Type:

duration

- Definition

The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityRegistrantName

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityTaxIdentificationNumber

Namespace Prefix:

dei_

Data Type:

dei:employerIdItemType

Balance Type:

Period Type:

duration

- Definition

Local phone number for entity.

+ References

No definition available.

+ Details

Name:

dei_LocalPhoneNumber

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 13e

-Subsection 4c

+ Details

Name:

dei_PreCommencementIssuerTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14d

-Subsection 2b

+ Details

Name:

dei_PreCommencementTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Title of a 12(b) registered security.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b

+ Details

Name:

dei_Security12bTitle

Namespace Prefix:

dei_

Data Type:

dei:securityTitleItemType

Balance Type:

Period Type:

duration

- Definition

Name of the Exchange on which a security is registered.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection d1-1

+ Details

Name:

dei_SecurityExchangeName

Namespace Prefix:

dei_

Data Type:

dei:edgarExchangeCodeItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14a

-Subsection 12

+ Details

Name:

dei_SolicitingMaterial

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Trading symbol of an instrument as listed on an exchange.

+ References

No definition available.

+ Details

Name:

dei_TradingSymbol

Namespace Prefix:

dei_

Data Type:

dei:tradingSymbolItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 230

-Section 425

+ Details

Name:

dei_WrittenCommunications

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration